SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-006886
Filing Date
2019-10-28
Accepted
2019-10-28 17:20:32
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_102819p.htm 10-Q 576175
2 EXHIBIT 31.1 exh_311.htm EX-31.1 9644
3 EXHIBIT 31.2 exh_312.htm EX-31.2 9629
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4765
  Complete submission text file 0001171843-19-006886.txt   3819921

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE anik-20190930.xml EX-101.INS 761095
6 XBRL SCHEMA FILE anik-20190930.xsd EX-101.SCH 48557
7 XBRL CALCULATION FILE anik-20190930_cal.xml EX-101.CAL 43102
8 XBRL DEFINITION FILE anik-20190930_def.xml EX-101.DEF 307828
9 XBRL LABEL FILE anik-20190930_lab.xml EX-101.LAB 268938
10 XBRL PRESENTATION FILE anik-20190930_pre.xml EX-101.PRE 335471
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 191173881
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services